Package 59417-103-10

Brand: vyvanse

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 59417-103-10
Digits Only 5941710310
Product NDC 59417-103
Product ID 59417-103_78225b65-2133-4c6c-bfde-0f2b26e5b19f
Description

100 CAPSULE in 1 BOTTLE (59417-103-10)

Marketing

Marketing Status
Marketed Since 2007-02-23
Brand vyvanse
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

Vyvanse ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "78225b65-2133-4c6c-bfde-0f2b26e5b19f", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854832", "854834", "854836", "854838", "854840", "854842", "854844", "854846", "854848", "854850", "854852", "1593856", "1593858", "1871456", "1871459", "1871460", "1871461", "1871462", "1871463", "1871464", "1871465", "1871466", "1871467", "1871468", "1871469"], "spl_set_id": ["704e4378-ca83-445c-8b45-3cfa51c1ecad"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (59417-103-10)", "package_ndc": "59417-103-10", "marketing_start_date": "20070223"}], "brand_name": "Vyvanse", "product_id": "59417-103_78225b65-2133-4c6c-bfde-0f2b26e5b19f", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "59417-103", "dea_schedule": "CII", "generic_name": "lisdexamfetamine dimesylate", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vyvanse", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "NDA021977", "marketing_category": "NDA", "marketing_start_date": "20070223", "listing_expiration_date": "20261231"}